Skip to content
Desk openThe Resource for Chief Operating OfficersLast update 2026-11-16Q&ANewsArticleInterview

News

OPS-0013 · 2026-11-16
Filed

Clinical Trial Supply and Logistics - Global Strategic Business Report 2026: Secure Share of the $5.7B Market by 2032 as Catalent, IQVIA, ICON, Almac Group and Lonza Accelerate Cold-Chain Scale

COO InsiderNovember 16, 2026

Boost ROI with real-time tracking, AI analytics, blockchain, resilient cold chains and CRO outsourcing to improve visibility, compliance and global trial efficiency.

Dublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- "Clinical Trial Supply and Logistics - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.

Global Clinical Trial Supply and Logistics Market to Reach US$5.7 Billion by 2032

The global clinical trial supply and logistics market, valued at US$3.6 billion in 2025, is projected to reach US$5.7 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.9%. The market outlook reflects increasing demand for reliable, compliant and technology-enabled supply chain services supporting clinical research worldwide.

Clinical trial supply and logistics operations cover investigational product sourcing, manufacturing, packaging, labeling, blinding, storage, retention and distribution. Effective coordination among pharmaceutical companies, biotechnology businesses, contract research organizations (CROs), medical device manufacturers and logistics providers is essential as clinical studies become more complex and geographically dispersed.

Clinical Trial Supply and Logistics Market Trends and Growth Drivers

Globalization is reshaping clinical trial logistics as sponsors conduct multi-site studies across jurisdictions with different regulatory, customs and distribution requirements. This expansion is increasing demand for integrated logistics networks capable of maintaining product integrity, supporting regulatory compliance and minimizing supply disruptions.

The growth of biologics, cell and gene therapies and personalized medicines is also creating demand for specialized storage, packaging and transportation. Many investigational products require tightly controlled temperatures, continuous monitoring and validated handling processes. As a result, investment in cold chain infrastructure, temperature-controlled packaging and shipment monitoring continues to accelerate.

Digital transformation is improving clinical trial supply chain visibility and resilience. Real-time tracking platforms enable stakeholders to monitor shipment location and condition, while artificial intelligence and predictive analytics support inventory planning, demand forecasting and risk management. Blockchain applications are also being evaluated to strengthen data integrity, traceability and security across clinical trial operations.

Lessons from the COVID-19 pandemic continue to influence supply chain strategy. Pharmaceutical and biotechnology companies are prioritizing agile distribution models, diversified supplier networks and contingency planning. At the same time, increased outsourcing to CROs and specialist logistics providers is creating additional opportunities for companies with global infrastructure and therapeutic expertise.

Report Scope

The report analyzes the clinical trial supply and logistics market by value in US dollars, covering the following segments:

  • Service: Logistics and distribution services; comparator sourcing services; manufacturing services; packaging, labeling and blinding services; storage and retention services; and other services.
  • Trial phase: Phase I, Phase II, Phase III and Phase IV trials.
  • Application: Cardiovascular diseases, oncology, respiratory diseases, central nervous system and mental disorders, and other applications.
  • End use: Pharmaceuticals, medical devices and biologicals.
  • Geography: United States, Canada, Japan, China, Europe, Asia-Pacific, Latin America, the Middle East and Africa, with analysis of major countries within each region.

Key Market Insights

  • The logistics and distribution services segment is forecast to reach US$1.5 billion by 2032, growing at a CAGR of 7.3%.
  • Comparator sourcing services are projected to expand at a CAGR of 6.3% during the analysis period.
  • The United States clinical trial supply and logistics market is valued at US$978 million in 2025.
  • China is forecast to grow at a CAGR of 10.5%, reaching approximately US$1.2 billion by 2032.
  • Japan, Canada, Germany and the wider Asia-Pacific region are also assessed for emerging opportunities, competitive activity and long-term growth potential.

Strategic Value of the Report

  • Independent market forecasts and annual sales analysis from 2025 through 2032.
  • Detailed evaluation of major services, trial phases, therapeutic applications and end-use markets.
  • Regional intelligence covering established and emerging clinical research markets.
  • Analysis of market drivers, constraints, technology trends and regulatory considerations.
  • Competitive insights designed to support investment planning, market entry, partnership development and revenue strategy.
  • Company profiles and one year of complimentary report updates.

Questions Addressed

  • How will the global clinical trial supply and logistics market evolve through 2032?
  • Which factors are driving or restricting market expansion?
  • Which service categories, trial phases and applications offer the strongest growth prospects?
  • How are regional competitive positions expected to change?
  • Which companies are influencing the market, and what are their strategic prospects?

Companies Featured

Companies covered in the clinical trial supply and logistics market report include Almac Group, Bilcare Ltd., Biocair International Ltd., Catalent, Inc., Eurofins Scientific SE, Experic, ICON plc, Intertek Group PLC, IQVIA Inc., Lonza Group Ltd., Movianto, Oximio, Parexel International (MA) Corporation, PCI Pharma Services and Piramal Pharma Solutions.

Domain Expert Insights and Differentiated Intelligence

  • Expert perspectives: The analysis incorporates insights from specialists across industry, enterprise and academia to provide context beyond conventional published research.
  • Early market signals: The report tracks developments emerging from expert discussions, corporate activity and market-relevant conversations before they are fully reflected in traditional secondary research.
  • Validated intelligence: Findings draw on conference sessions, executive keynotes, panel discussions, corporate disclosures, annual reports, institutional publications and other credible sources.
  • Strategic direction: The report connects market signals with the forces shaping clinical trial supply chain investment, technology adoption and competitive positioning.
  • Company intelligence: Coverage extends beyond market-level forecasts to examine organizations participating in and influencing the competitive environment.
  • Relevant market share analysis: Competitive structures are assessed across major regions where market share evaluation provides meaningful strategic insight.

This comprehensive clinical trial supply and logistics market report equips decision-makers with actionable intelligence on growth opportunities, regional demand, service innovation and competitive dynamics through 2032.

Key Attributes:

Report Attribute Details
No. of Pages 503
Forecast Period 2025 - 2032
Estimated Market Value (USD) in 2025 $3.6 Billion
Forecasted Market Value (USD) by 2032 $5.7 Billion
Compound Annual Growth Rate 6.9%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/1fwyzp

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900